<DOC>
	<DOCNO>NCT00667134</DOCNO>
	<brief_summary>This study determine subject .systemic sclerosis stimulatory autoantibody PDGF receptor confirm activation ( phosphorylation ) PDGF receptor skin sit vary degree skin thicken</brief_summary>
	<brief_title>Stimulatory Autoantibodies Platelet-Derived Growth Factor Receptor ( PDGFR ) Patients With Systemic Sclerosis</brief_title>
	<detailed_description>Pilot study ass whether patient systemic sclerosis stimulatory autoantibody PDGF receptor confirm activation ( phosphorylation ) PDGF receptor skin sit vary degree skin thicken</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>1 . Fulfill American College Rheumatology criterion systemic sclerosis : 2 . Have disease result primary fibrosis organ system , include skin autoimmune disease 1 . If subject systemic sclerosis result environmental exposure 2 . If subject autoimmune disease exclude scleroderma 3 . If subject active infection ( include , limited hepatitis B , hepatitis C HIV ) 4 . If subject treat cyclophosphamide past 8 week . 5 . If subject prone bleeding medication thin blood low platelet count .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>systemic sclerosis autoantibody</keyword>
</DOC>